Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pociredir (FTX-6058) is a potent, selective and orally active inhibitor of embryonic ectoderm development (EED) (KD= 0.163 nM). Pociredir (FTX-6058) has research value in inflammatory or hemoglobinopathies, such as sickle cell disease (SCD).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 491,500 |
50 mg | 約10-14 週間 | ¥ 639,500 |
100 mg | 約10-14 週間 | ¥ 808,000 |
説明 | Pociredir (FTX-6058) is a potent, selective and orally active inhibitor of embryonic ectoderm development (EED) (KD= 0.163 nM). Pociredir (FTX-6058) has research value in inflammatory or hemoglobinopathies, such as sickle cell disease (SCD). |
In vivo | Pociredir (FTX-6058) (QD, 5 mg/kg) reduces the H3K27me3 levels in the Townes mouse model of sickle cell disease (SCD). Pociredir (FTX-6058) (QD, 5 mg/kg) increases the levels of red blood cells and total hemoglobin, ameliorates hemolysis in the Townes mouse model of sickle cell disease (SCD) [1]. |
分子量 | 403.41 |
分子式 | C22H18FN5O2 |
CAS No. | 2490674-02-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pociredir 2490674-02-5 Inhibitor inhibitor inhibit